Picture of Stayble Therapeutics AB logo

STABL Stayble Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Stayble Therapeutics Q1 EBIT Loss Widens To SEK 7.5 Mln

May 17 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * Q1 EBIT LOSS SEK 7.5 MILLION VERSUS LOSS SEK 2.1 MILLION
YEAR
AGO
    * Q1 NET LOSS SEK 7.6 MILLION VERSUS LOSS SEK 2.1 MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr9x2JLt 
Further company coverage:  STABL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Stayble Therapeutics AB

See all news